Evidence map›Paper›PMID 33088512›Full record

ArticleClinical case reports2020

A case of insulinoma effectively treated with low-dose diazoxide.

Atsushi Yasuda, Toshiro Seki, Natsumi Kitajima, Tanefumi Baba, Noriko Sasaki, Yoshie Kametani, Masami Seki, Kazuko Tanaka, Masayuki Oki

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Atsushi YasudaDivision of Nephrology, Endocrinology and Metabolism Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.ORCID https://orcid.org/0000-0002-7397-766X
Toshiro SekiDivision of Nephrology, Endocrinology and Metabolism Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.ORCID https://orcid.org/0000-0002-1963-5140
Natsumi KitajimaDivision of Nephrology, Endocrinology and Metabolism Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.ORCID https://orcid.org/0000-0002-8410-3175
Tanefumi BabaDepartment of Neurosurgery Tokai University School of Medicine Kanagawa Japan.ORCID https://orcid.org/0000-0003-3435-2322
Noriko SasakiDivision of Rheumatology Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.
Yoshie KametaniDepartment of Molecular Life Science Division of Basic Medical Science Tokai University School of Medicine Kanagawa Japan.ORCID https://orcid.org/0000-0002-7417-1836
Masami SekiSeirei Numazu Hospital Shizuoka Japan.ORCID https://orcid.org/0000-0002-6182-7728
Kazuko TanakaDivision of General Internal Medicine Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.
Masayuki OkiDivision of General Internal Medicine Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.ORCID https://orcid.org/0000-0003-4638-1569
Tokai University · JPNumazu City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diazoxide is a benzothiadiazine that can be effective in managing hypoglycemia in frail patients with surgical risk. We report here a case of insulinoma effectively treated with diazoxide, as our report will be helpful for similar cases.

Indexed as

diazoxidehypoglycemiainsulinomaneuroendocrine tumor

Identifiers

PMID33088512
PMCPMC7562850
OpenAlexW3033049523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.